vs

Side-by-side financial comparison of NeuroPace Inc (NPCE) and Rhinebeck Bancorp, Inc. (RBKB). Click either name above to swap in a different company.

NeuroPace Inc is the larger business by last-quarter revenue ($26.6M vs $13.5M, roughly 2.0× Rhinebeck Bancorp, Inc.). Rhinebeck Bancorp, Inc. runs the higher net margin — 17.3% vs -10.3%, a 27.6% gap on every dollar of revenue. On growth, Rhinebeck Bancorp, Inc. posted the faster year-over-year revenue change (1701.1% vs 23.9%). Rhinebeck Bancorp, Inc. produced more free cash flow last quarter ($10.9M vs $409.0K). Over the past eight quarters, NeuroPace Inc's revenue compounded faster (21.1% CAGR vs 14.0%).

NeuroPace Inc is a medical technology company focused on developing and commercializing innovative implantable neurostimulation systems to treat neurological disorders, primarily drug-resistant epilepsy. Its core RNS System delivers personalized responsive stimulation to reduce seizure frequency, serving patients across North America and select global markets via partnerships with healthcare providers.

Rhinebeck Bancorp, Inc. is a US regional bank holding company based in New York. It operates Rhinebeck Bank, offering retail and commercial banking services including deposit accounts, loans, mortgages and wealth management, mainly serving consumers and small-to-medium businesses across New York's Hudson Valley region.

NPCE vs RBKB — Head-to-Head

Bigger by revenue
NPCE
NPCE
2.0× larger
NPCE
$26.6M
$13.5M
RBKB
Growing faster (revenue YoY)
RBKB
RBKB
+1677.2% gap
RBKB
1701.1%
23.9%
NPCE
Higher net margin
RBKB
RBKB
27.6% more per $
RBKB
17.3%
-10.3%
NPCE
More free cash flow
RBKB
RBKB
$10.5M more FCF
RBKB
$10.9M
$409.0K
NPCE
Faster 2-yr revenue CAGR
NPCE
NPCE
Annualised
NPCE
21.1%
14.0%
RBKB

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
NPCE
NPCE
RBKB
RBKB
Revenue
$26.6M
$13.5M
Net Profit
$-2.7M
$2.3M
Gross Margin
77.4%
Operating Margin
-6.6%
21.7%
Net Margin
-10.3%
17.3%
Revenue YoY
23.9%
1701.1%
Net Profit YoY
48.0%
188.0%
EPS (diluted)
$-0.08
$0.21

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NPCE
NPCE
RBKB
RBKB
Q4 25
$26.6M
$13.5M
Q3 25
$27.4M
$14.0M
Q2 25
$23.5M
$13.1M
Q1 25
$22.5M
$12.8M
Q4 24
$21.5M
$750.0K
Q3 24
$21.1M
$773.0K
Q2 24
$19.3M
$10.7M
Q1 24
$18.1M
$10.4M
Net Profit
NPCE
NPCE
RBKB
RBKB
Q4 25
$-2.7M
$2.3M
Q3 25
$-3.5M
$2.7M
Q2 25
$-8.7M
$2.7M
Q1 25
$-6.6M
$2.3M
Q4 24
$-5.3M
$-2.7M
Q3 24
$-5.5M
$-8.1M
Q2 24
$-7.5M
$975.0K
Q1 24
$-8.9M
$1.1M
Gross Margin
NPCE
NPCE
RBKB
RBKB
Q4 25
77.4%
Q3 25
77.4%
Q2 25
77.1%
Q1 25
77.0%
Q4 24
75.4%
Q3 24
73.2%
Q2 24
73.4%
Q1 24
73.6%
Operating Margin
NPCE
NPCE
RBKB
RBKB
Q4 25
-6.6%
21.7%
Q3 25
-9.5%
23.9%
Q2 25
-29.0%
26.6%
Q1 25
-22.9%
22.9%
Q4 24
-17.0%
-444.9%
Q3 24
-20.1%
-1332.3%
Q2 24
-32.4%
11.8%
Q1 24
-41.6%
13.9%
Net Margin
NPCE
NPCE
RBKB
RBKB
Q4 25
-10.3%
17.3%
Q3 25
-12.8%
19.3%
Q2 25
-36.8%
20.8%
Q1 25
-29.3%
17.9%
Q4 24
-24.5%
-353.9%
Q3 24
-25.9%
-1042.9%
Q2 24
-39.0%
9.2%
Q1 24
-49.2%
10.8%
EPS (diluted)
NPCE
NPCE
RBKB
RBKB
Q4 25
$-0.08
$0.21
Q3 25
$-0.11
$0.25
Q2 25
$-0.26
$0.25
Q1 25
$-0.21
$0.21
Q4 24
$-0.16
$-0.24
Q3 24
$-0.19
$-0.75
Q2 24
$-0.26
$0.09
Q1 24
$-0.32
$0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NPCE
NPCE
RBKB
RBKB
Cash + ST InvestmentsLiquidity on hand
$61.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$19.0M
$136.9M
Total Assets
$105.6M
$1.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NPCE
NPCE
RBKB
RBKB
Q4 25
$61.1M
Q3 25
$60.0M
Q2 25
$62.1M
Q1 25
$66.3M
Q4 24
$52.8M
Q3 24
$56.8M
Q2 24
$55.5M
Q1 24
$58.9M
Stockholders' Equity
NPCE
NPCE
RBKB
RBKB
Q4 25
$19.0M
$136.9M
Q3 25
$18.5M
$133.0M
Q2 25
$19.4M
$129.0M
Q1 25
$24.3M
$126.0M
Q4 24
$8.0M
$121.8M
Q3 24
$9.8M
$122.7M
Q2 24
$9.9M
$116.2M
Q1 24
$14.3M
$114.3M
Total Assets
NPCE
NPCE
RBKB
RBKB
Q4 25
$105.6M
$1.3B
Q3 25
$107.3M
$1.3B
Q2 25
$106.1M
$1.3B
Q1 25
$110.2M
$1.3B
Q4 24
$94.6M
$1.3B
Q3 24
$96.3M
$1.3B
Q2 24
$94.4M
$1.3B
Q1 24
$98.9M
$1.3B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NPCE
NPCE
RBKB
RBKB
Operating Cash FlowLast quarter
$506.0K
$11.7M
Free Cash FlowOCF − Capex
$409.0K
$10.9M
FCF MarginFCF / Revenue
1.5%
80.6%
Capex IntensityCapex / Revenue
0.4%
6.3%
Cash ConversionOCF / Net Profit
5.03×
TTM Free Cash FlowTrailing 4 quarters
$-11.3M
$19.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NPCE
NPCE
RBKB
RBKB
Q4 25
$506.0K
$11.7M
Q3 25
$-1.9M
$2.2M
Q2 25
$-2.1M
$2.4M
Q1 25
$-7.5M
$4.3M
Q4 24
$-4.8M
$8.5M
Q3 24
$-1.7M
$-3.6M
Q2 24
$-3.9M
$12.0M
Q1 24
$-7.5M
$-3.5M
Free Cash Flow
NPCE
NPCE
RBKB
RBKB
Q4 25
$409.0K
$10.9M
Q3 25
$-2.0M
$2.0M
Q2 25
$-2.3M
$2.2M
Q1 25
$-7.5M
$4.2M
Q4 24
$-4.8M
$7.7M
Q3 24
$-1.8M
$-3.6M
Q2 24
$-4.0M
$11.8M
Q1 24
$-7.6M
$-3.7M
FCF Margin
NPCE
NPCE
RBKB
RBKB
Q4 25
1.5%
80.6%
Q3 25
-7.2%
14.5%
Q2 25
-9.6%
17.2%
Q1 25
-33.4%
32.8%
Q4 24
-22.5%
1023.9%
Q3 24
-8.7%
-469.0%
Q2 24
-20.6%
111.1%
Q1 24
-42.1%
-36.0%
Capex Intensity
NPCE
NPCE
RBKB
RBKB
Q4 25
0.4%
6.3%
Q3 25
0.1%
1.4%
Q2 25
0.7%
1.4%
Q1 25
0.2%
0.9%
Q4 24
0.2%
105.5%
Q3 24
0.5%
6.3%
Q2 24
0.3%
1.2%
Q1 24
0.6%
2.3%
Cash Conversion
NPCE
NPCE
RBKB
RBKB
Q4 25
5.03×
Q3 25
0.83×
Q2 25
0.89×
Q1 25
1.89×
Q4 24
Q3 24
Q2 24
12.27×
Q1 24
-3.12×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons